Russell Investments »

Enliven Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $34k 1.4k 23.37
2024-03-31 $210 12 17.58
2023-12-31 $165 12 13.83

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Eli Lilly And Company Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Welltower Common Stock (WELL)
Prologis Common Stock (PLD)
Digital Realty Trust Common Stock (DLR)
J P Morgan Chase And Common Stock (JPM)

View all positions for Russell Investments

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics